Departamento de Fisiologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Cell Biochem Funct. 2011 Oct;29(7):617-23. doi: 10.1002/cbf.1796.
This study was conducted to analyse the redox status and redox-sensitive proteins that may contribute to a non-genomic mechanism of cardiac hypertrophy induction by hyperthyroidism. Wistar rats, treated with L-thyroxine (T4) during 2 weeks (12 mg·l(-1) in drinking water), presented cardiac hypertrophy (68% higher than control), without signals of liver or lung congestion. Myocardial reduction of the reduced glutathione: oxidized glutathione (GSSG) ratio (45%) (redox status) and elevation in hydrogen peroxide concentration (H(2) O(2) ) (28%) were observed in hyperthyroid as compared with the control. No significant difference was found in thioredoxin (Trx), Trx reductase activity and Nrf2 (a transcriptional factor) protein expression between groups. Redox-sensitive proteins, quantified using Western blot, presented the following results: increased p-ERK: total extracellular-regulated kinase (ERK) (200%) and Bax:Bcl-2 (62%) ratios and reduced total-Akt (63%) and p-Akt (53%) expressions in the hyperthyroid rats as compared with the control. The redox imbalance, associated with increased immunocontent of a protein related to maladaptative growth (ERK) and reduced immunocontent of protein related to cytoprotection/survival (Akt), may suggest that the molecular scenario could favour the decompensation process of cardiac hypertrophy induced by experimental hyperthyroidism.
这项研究旨在分析氧化还原状态和氧化还原敏感蛋白,这些可能是甲状腺功能亢进诱导心脏肥厚的非基因组机制的贡献因素。在为期 2 周的时间里,用 L-甲状腺素(T4)处理 Wistar 大鼠(在饮用水中 12mg·l(-1)),导致心脏肥厚(比对照组高 68%),没有肝脏或肺部充血的迹象。与对照组相比,甲状腺功能亢进大鼠心肌中还原型谷胱甘肽:氧化型谷胱甘肽(GSSG)比值(氧化还原状态)降低了 45%,过氧化氢浓度(H₂O₂)升高了 28%。Trx、Trx 还原酶活性和 Nrf2(一种转录因子)蛋白表达在两组之间没有显著差异。使用 Western blot 定量的氧化还原敏感蛋白,结果如下:与对照组相比,甲状腺功能亢进大鼠中的 p-ERK:总细胞外调节激酶(ERK)(200%)和 Bax:Bcl-2(62%)比值增加,总-Akt(63%)和 p-Akt(53%)表达减少。氧化还原失衡与与适应性生长(ERK)相关的蛋白免疫含量增加和与细胞保护/存活(Akt)相关的蛋白免疫含量减少有关,这可能表明分子情况可能有利于实验性甲状腺功能亢进引起的心脏肥厚失代偿过程。